Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 100.
394. lappuse
... Accurately weigh approximately 110 milligrams of the loracarbef working standard into a suitable - sized volumetric flask . Dis- solve and dilute to volume with water . Further dilute an accurately measured portion with distilled water ...
... Accurately weigh approximately 110 milligrams of the loracarbef working standard into a suitable - sized volumetric flask . Dis- solve and dilute to volume with water . Further dilute an accurately measured portion with distilled water ...
412. lappuse
... Accurately weigh approximately 50 milligrams of the working standard of the antibiotic to be tested and dissolve with 25 milli- liters of 0.1N hydrochloric acid . Quan- titatively transfer to a 250 - milliliter volumetric flask and ...
... Accurately weigh approximately 50 milligrams of the working standard of the antibiotic to be tested and dissolve with 25 milli- liters of 0.1N hydrochloric acid . Quan- titatively transfer to a 250 - milliliter volumetric flask and ...
423. lappuse
... accurately weighed , into a 50 - milliliter volumetric flask . Add 25 to 30 milli- liters of mobile phase . Shake until dis- solved . Dilute to volume with mobile phase . ( 2 ) Sample solution— ( i ) Micrograms per milligram . Place ...
... accurately weighed , into a 50 - milliliter volumetric flask . Add 25 to 30 milli- liters of mobile phase . Shake until dis- solved . Dilute to volume with mobile phase . ( 2 ) Sample solution— ( i ) Micrograms per milligram . Place ...
426. lappuse
... accurately weighed portion of the cephradine working standard into a suitably sized container . Add 5.0 milli- liters of distilled water and place in an ultrasonic bath to facilitate dissolu- tion . Dilute with a sufficient amount of ...
... accurately weighed portion of the cephradine working standard into a suitably sized container . Add 5.0 milli- liters of distilled water and place in an ultrasonic bath to facilitate dissolu- tion . Dilute with a sufficient amount of ...
428. lappuse
... accurately weighed , with mobile phase to obtain a solution containing 0.16 milligram of cefoperazone activity per milliliter . ( e ) Preparation of sample solutions— ( 1 ) Product not packaged for dispensing ( micrograms of ...
... accurately weighed , with mobile phase to obtain a solution containing 0.16 milligram of cefoperazone activity per milliliter . ( e ) Preparation of sample solutions— ( 1 ) Product not packaged for dispensing ( micrograms of ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning